Viewing StudyNCT00351468



Ignite Creation Date: 2024-05-05 @ 4:58 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00351468
Status: COMPLETED
Last Update Posted: 2017-04-17
First Post: 2006-07-10

Brief Title: EXTEND Eltrombopag Extended Dosing Study
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Purpura Thrombocytopaenic Idiopathic
Keywords:
Name View
platelets View
eltrombopag olamine View
SB-497115-GR View
idiopathic thrombocytopenic purpura View
thrombocytopenia View
ITP View